Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Epizyme + 20 Stocks Moving In Monday's Pre-Market Session

Published 27/06/2022, 11:31
Updated 27/06/2022, 12:10
© Reuters.  Epizyme + 20 Stocks Moving In Monday's Pre-Market Session

Gainers

  • Tenax Therapeutics, Inc. (NASDAQ: TENX) rose 90.1% to $0.59 in pre-market trading after dipping more than 46% on Friday.
  • Epizyme, Inc. (NASDAQ: EPZM) rose 57.2% to $1.50 in pre-market trading after Ipsen announced plans to acquire the company.
  • Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 49.2% to $0.5550 in pre-market trading after jumping 17% on Friday.
  • FedNat Holding Company (NASDAQ: FNHC) rose 30.4% to $0.3389 in pre-market trading after dipping over 20% on Friday. FedNat, last month, announced a $15 million investment by Hale Partnership in Monarch National Insurance Company.
  • InflaRx N.V. (NASDAQ: IFRX) shares rose 28% to $0.9995 in pre-market trading after tumbling around 34% on Friday.
  • Ebang International Holdings Inc. (NASDAQ: EBON) rose 18.7% to $0.4401 in pre-market trading. Ebang International announced the receipt of Nasdaq notification regarding minimum bid price deficiency.
  • Kiromic BioPharma, Inc. (NASDAQ: KRBP) rose 16.7% to $0.42 in pre-market trading after dropping more than 25% on Friday. Kiromic BioPharma recently announced a strategic pipeline shift to prioritize its allogeneic, non-engineered off-the-shelf product candidate, Deltacel/KB-GDT.
  • Reed's, Inc. (NASDAQ: REED) rose 14.4% to $0.1601 in pre-market trading after dropping more than 20% on Friday. Reed's, last month, posted a Q1 loss of $0.05 per share.
  • AppTech Payments Corp. (NASDAQ: APCX) rose 13.8% to $0.70 in pre-market trading after gaining around 15% on Friday.
  • Applied Genetic Technologies Corporation (NASDAQ: AGTC) shares rose 13.5% to $0.70 in pre-market trading following a 25% drop on Friday.
  • Minerva Neurosciences, Inc. (NASDAQ: NERV) rose 13.3% to $3.59 in pre-market trading after gaining more than 9% on Friday.
  • American Virtual Cloud Technologies, Inc. (NASDAQ: AVCT) rose 11.9% to $0.34 in pre-market trading following a 9% decline on Friday.
  • ToughBuilt Industries, Inc. (NASDAQ: TBLT) rose 10.3% to $2.98 in pre-market trading after jumping 55% on Friday. ToughBuilt Industries recently announced closing of $6 million public offering.
  • RedHill Biopharma Ltd. (NASDAQ: RDHL) rose 9.8% to $0.90 in pre-market trading. RedHill Biopharma recently announced a cost reduction plan expected to generate operational cost savings of approximately $50 million over the next 18 months.
  • Sorrento Therapeutics, Inc. (NASDAQ: SRNE) rose 9.2% to $2.26 in pre-market trading. Sorrento Therapeutics named Honorable Tommy G. Thompson, former Secretary of the United States Department of Health and Human Services and former Governor of Wisconsin, as Covid-19 special consultant to Sorrento’s Chairman and CEO Henry Ji.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Losers

  • JE Cleantech Holdings Limited (NASDAQ: JCSE) fell 15% to $10.73 in pre-market trading after dropping more than 28% on Friday.
  • SIGA Technologies, Inc. (NASDAQ: SIGA) fell 12.6% to $11.40 in pre-market trading. SIGA Technologies recently announced approximately $13 million in procurement orders for oral TPOXX (tecovirimat).
  • Vivakor, Inc. (NASDAQ: VIVK) fell 9.8% to $2.13 in pre-market trading. Vivakor recently announced it signed a definitive agreement to acquire Silver Fuels Delhi and White Claw Colorado City.
  • ShiftPixy, Inc. (NASDAQ: PIXY) fell 8.8% to $0.28 in pre-market trading after tumbling over 10% on Friday.
  • Sharecare, Inc. (NASDAQ: SHCR) shares fell 7.8% to $1.77 in pre-market trading. Sharecare, last month, reported better-than-expected Q1 EPS and sales results, issued Q2 and FY22 guidance and reported a $50 million buyback.
  • Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) fell 7% to $1.74 in pre-market trading. Tonix Pharmaceuticals recently reported pricing of $30 million private placement of convertible redeemable preferred stock.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.